Point/Counterpoint: Does FOLFIRINOX Offer a New Standard of Care for Metastatic Pancreatic Cancer? Interview with Dr. Margaret Tempero and Dr. Axel Grothey
Point/Counterpoint: Does FOLFIRINOX Offer a New Standard of Care for Metastatic Pancreatic Cancer? Interview with Dr. Margaret Tempero and Dr. Axel Grothey
Interview by L Scott Zoeller
20100609
2010 Jul 9
OncologySTAT Editorial Team
Point/Counterpoint: Does FOLFIRINOX Offer a New Standard of Care for Metastatic Pancreatic Cancer? Interview with Dr. Margaret Tempero and Dr. Axel Grothey
OncologySTAT Editorial Team. 2010 Jul 9, Interview by L Scott Zoeller
Dr. Margaret Tempero is Deputy Director and Director of Clinical Sciences of the UCSF Helen Diller Family Comprehensive Cancer Center, and Professor of Medicine in the Department of Medicine at the University of California, San Francisco. View her profile. Dr. Axel Grothey is Professor of Oncology and Consultant in the Division of Medical Oncology at the Mayo Clinic in Rochester, MN. View his profile.During the ASCO 2010 annual meeting, Dr. Thierry Conroy presented the remarkable final results from...
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
